Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier. (2021)
Attributed to:
Cost effectiveness of patient-matched pre- and on-treatment biomarkers in cancer therapy response prediction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s40273-020-00983-7
PubMed Identifier: 33225423
Publication URI: http://europepmc.org/abstract/MED/33225423
Type: Journal Article/Review
Volume: 39
Parent Publication: PharmacoEconomics
Issue: 1
ISSN: 1170-7690